Good Morning!
We were riding so high on our recent wave of trades that critical NEWS from
TapImmune Inc. (TPIV) almost slipped past us.
You know that breast cancer vaccine TPIV has been working on for ages? There’s finally enough shots to start the clinical trial!
Is it any wonder the chart is on an upswing? The ramp toward the FDA can move biotech giants, so here’s little TPIV racing back above $0.60.
But even above $0.60, there’s still a LONG way to go. And as it happens, this is an interesting technical moment to get TPIV back on your radar:
Rising highs, rising lows! Now that biotech is back in Wall Street’s good graces, we may just be looking at the early stages of a MONSTER rally!
TPIV is on the fast track to cancer vaccines, most recently getting an FDA green light to hit the clinic with an ovarian cancer cure.
We rode that buzz from $0.50 to as high as $0.67 a few months back, which is a nice 34% for the effort.
Meanwhile TPIV was working on manufacturing the clinical doses for both ovary and breast cancer so they can launch multiple trials fast.
Phase I did well! Now it’s time for the company and the stock to shift into Phase II with at least FOUR shots on goal in the next 8 months!
With that story to work with, it’s no wonder TPIV is on that ramp. RSI and MACD both confirm the bull trend up there.
What’s interesting, of course, is the channel TPIV has been following. We’re near a floor here around $0.60. Implied TOP could be in the $0.80 zone.
Just rolling from this floor to the top of the channel can unlock big win in a remarkably easy period of time. TPIV has given us that in the past.
There’s no “breakout” baked into that scenario, no need for any catalyst. If that happens, the simmer can turn to SIZZLE!
Of course I’m not ruling out a breakout here. TPIV’s cancer technology blows away the occasional analyst, especially at this ground floor price.
But should TPIV leap the channel today, I think we’ll all be delighted in any event. Enough from me, time to TRADE!
Sincerely,
Michael Reef
yourstockguy@gmail.com
